NEXGEL, Inc. (NXGL) vs Silo Pharma, Inc. (SILO)

A side-by-side comparison of NEXGEL, Inc. and Silo Pharma, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — NXGL vs SILO

growth of $100 · dividends reinvested · last 5y
NXGL -95.2% (-45.5%/yr)SILO -98.7% (-57.9%/yr)NXGL compounded faster over this window
050100150Start $10020222023202420252026$5$1
NXGL SILO

NXGL vs SILO: by the numbers

  • •SILO is the larger company ($2M vs $1M market cap).
  • •Both run net losses; NXGL's is the smaller (-51.26% vs -8269.53% net margin).
  • •NXGL grew revenue faster over the past five years (63.69% vs 0.29% CAGR).

Metrics side by side

Valuation

MetricNXGLSILO
P/S ratio0.1230.26
P/B ratio0.300.33

Profitability

MetricNXGLSILO
Gross margin35.07%-1128.89%
Operating margin-29.35%-5936.95%
Net margin-51.26%-8269.53%
ROE-124.97%-91.52%
ROIC-41.80%-91.31%

Growth (annualized)

MetricNXGLSILO
Revenue CAGR (5Y)63.69%0.29%
Total return CAGR (5Y)N/A-61.41%

Frequently asked

Which has grown faster, NXGL or SILO?
Over the past five years, NXGL grew revenue faster — NXGL at a 63.69% CAGR versus SILO at 0.29%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.